• Explore /
  • Poster
  • / CEA response at four weeks as an early predictor for outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab-based chemotherapy: A STEP-analysis in the JACCRO CC-05/06 trials.

CEA response at four weeks as an early predictor for outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab-based chemotherapy: A STEP-analysis in the JACCRO CC-05/06 trials.

Abstract Poster

Authors

Yu Sunakawa

Yu Sunakawa

Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan

Yu Sunakawa , Xuemin Fang , Masahito Kotaka , Hiroaki Tanioka , Akinori Takagane , Satoshi Tani , Tatsuro Yamaguchi , Takanori Watanabe , Toshiki Masuishi , Masahiro Tsuda , Tatsuya Okuno , Takao Tamura , Kaoru Furushima , Hidekazu Kuramochi , Junichi Koike , Yutaka Yonemura , Hisateru Yasui , Masahiro Takeuchi , Masashi Fujii , Wataru Ichikawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

UMIN000004197 and UMIN000007022

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 543)

DOI

10.1200/JCO.2019.37.4_suppl.543

Abstract #

543

Poster Bd #

F6

Abstract Disclosures

Similar Posters

First Author: Yu Sunakawa

First Author: Thomas Seufferlein

First Author: S.P. Somashekhar

First Author: Andrew B. Nixon